ResMed, Inc. (RMD)
242.61
+4.76
(+2.00%)
USD |
NYSE |
Nov 18, 16:00
242.61
0.00 (0.00%)
Pre-Market: 07:54
ResMed EPS Diluted (Quarterly) : 2.918 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 2.918 |
| June 30, 2026 | 2.645 |
| March 31, 2026 | 2.736 |
| December 31, 2025 | 2.682 |
| September 30, 2025 | 2.373 |
| June 30, 2025 | 2.582 |
| March 31, 2025 | 2.480 |
| December 31, 2024 | 2.337 |
| September 30, 2024 | 2.110 |
| June 30, 2024 | 1.981 |
| March 31, 2024 | 2.038 |
| December 31, 2023 | 1.415 |
| September 30, 2023 | 1.488 |
| June 30, 2023 | 1.556 |
| March 31, 2023 | 1.577 |
| December 31, 2022 | 1.526 |
| September 30, 2022 | 1.430 |
| June 30, 2022 | 1.327 |
| March 31, 2022 | 1.218 |
| December 31, 2021 | 1.372 |
| September 30, 2021 | 1.386 |
| June 30, 2021 | 1.331 |
| March 31, 2021 | -0.5393 |
| December 31, 2020 | 1.226 |
| September 30, 2020 | 1.221 |
| Date | Value |
|---|---|
| June 30, 2020 | 1.219 |
| March 31, 2020 | 1.120 |
| December 31, 2019 | 1.103 |
| September 30, 2019 | 0.828 |
| June 30, 2019 | 0.4755 |
| March 31, 2019 | 0.7304 |
| December 31, 2018 | 0.86 |
| September 30, 2018 | 0.73 |
| June 30, 2018 | 0.7626 |
| March 31, 2018 | 0.76 |
| December 31, 2017 | 0.07 |
| September 30, 2017 | 0.60 |
| June 30, 2017 | 0.71 |
| March 31, 2017 | 0.62 |
| December 31, 2016 | 0.54 |
| September 30, 2016 | 0.54 |
| June 30, 2016 | 0.59 |
| March 31, 2016 | 0.64 |
| December 31, 2015 | 0.68 |
| September 30, 2015 | 0.57 |
| June 30, 2015 | 0.61 |
| March 31, 2015 | 0.64 |
| December 31, 2014 | 0.64 |
| September 30, 2014 | 0.58 |
| June 30, 2014 | 0.61 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Accuray, Inc. | 2.911 |
| Orthofix Medical, Inc. | -0.1475 |
| Rockwell Medical, Inc. | -0.5851 |
| Microbot Medical, Inc. | -0.087 |
| Stereotaxis, Inc. | -0.0663 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 418.41M |
| Revenue (Quarterly) | 1.415B |
| Total Expenses (Quarterly) | 996.40M |
| Enterprise Value | 33.70B |
| Gross Profit Margin (Quarterly) | 61.53% |
| Profit Margin (Quarterly) | 29.57% |
| Earnings Yield | 4.53% |
| Operating Earnings Yield | 5.53% |
| Normalized Earnings Yield | 4.573 |